Clinical Trial Update: Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the combination of docetaxel and estramustine in women with metastatic breast cancer; current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Estramustine (estramustine)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN